The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
Open accessAbstract
Objective: Hepatitis E virus (HEV) infection can take chronic courses in immunocompromised patients potentially leading to liver cirrhosis and liver failure. Ribavirin (RBV) is currently the only treatment option for many patients, but treatment failure can occur which has been associated with the appearance of a distinct HEV polymerase mutant (G1634R). Here, we performed a detailed analysis of HEV viral intrahost evolution during chronic hepatitis E infections. Design: Illumina deep sequencing was performed for the detection of intrahost variation in the HEV genome of chronically infected patients. Novel polymerase mutants were investigated in vitro using state-of-the-art HEV cell culture models. Results: Together, these data revealed that (1) viral diversity differed markedly between patients but did not show major intraindividual short-term variations in untreated patients with chronic hepatitis E, (2) RBV therapy was associated with an increase in viral heterogeneity which was reversible when treatment was stopped, (3) the G1634R mutant was detectable as a minor population prior to therapy in patients who subsequently failed to achieve a sustained virological response to RBV therapy and (4) in addition to G1634R further dominant variants in the polymerase region emerged, impacting HEV replication efficiency in vitro. Conclusions: In summary, this first investigation of intrahost HEV population evolution indicates that RBV causes HEV mutagenesis in treated patients and that an emergence of distinct mutants within the viral population occurs during RBV therapy. We also suggest that next-generation sequencing could be useful to guide personalised antiviral strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Viral error catastrophe by mutagenic nucleosides
Anderson, J. P., Daifuku, R., & Loeb, L. A. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123649 · Cited by 221
Cited by
EASL Clinical Practice Guidelines on hepatitis E virus infection
Dalton, H. R., Kamar, N., Baylis, S. A., Moradpour, D., Wedemeyer, H., & Negro, F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.005 · Cited by 665
Self-citationHepatitis E virus: advances and challenges
Nimgaonkar, I., Ding, Q., Schwartz, R. E., & Ploss, A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.150 · Cited by 352
Metadata
- Authors
- Todt, D., Gisa, A., Radonic, A., Nitsche, A., Behrendt, P., Suneetha, P. V., Pischke, S., Bremer, B., Brown, R. J. P., Manns, M. P., Cornberg, M., Bock, C. T., Steinmann, E., & Wedemeyer, H.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2016-05-24
- Volume
- 65
- Issue
- 10
- Pages
- 1733-1743
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2405561744
- Cited by
- 187
- References
- 1
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. https://app.cochat.ai/papers/10.1136/gutjnl-2015-311000
- The paper
- Todt, D., Gisa, A., Radonic, A., Nitsche, A., Behrendt, P., Suneetha, P. V., Pischke, S., Bremer, B., Brown, R. J. P., Manns, M. P., Cornberg, M., Bock, C. T., Steinmann, E., & Wedemeyer, H. (2016). In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut. https://doi.org/10.1136/gutjnl-2015-311000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.